Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart

Acta Physiologica

Volumn 193, Issue 1, 2008, Pages 25-36

  Killeen, M J ^a   Thomas, G ^a   Olesen, S P ^b,c   Demnitz, J ^b   Stokoe, K S ^a   Grace, A A ^a   Huang, C L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NEUROSEARCH A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Hypokalaemia; Mouse heart; Nicorandil; NS1643

Indexed keywords

NICORANDIL; NS 1643; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; ELECTROSTIMULATION; EPICARDIUM; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HYPOKALEMIA; ISOLATED HEART; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CRESOLS; ELECTRIC STIMULATION; FEMALE; HEART; HYPOKALEMIA; ION CHANNEL GATING; MALE; MICE; NICORANDIL; ORGAN CULTURE TECHNIQUES; PHENYLUREA COMPOUNDS; POTASSIUM CHANNELS;

EID: 41749119864     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2007.01773.x     Document Type: Article

References (47)

1. Babij, P., Askew, G.R., Nieuwenhuijsen, B., Su, C.M., Bridal, T.R., Jow, B., Argentieri, T.M., Kulik, J., DeGennaro, L.J., Spinelli, W. Colatsky, T.J. 1998. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. Circ Res 83, 668 678.
2. Balasubramaniam, R., Grace, A.A., Saumarez, R.C., Vandenberg, J.I. Huang, C.L. 2003. Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 552, 535 546.
3. Bellocq, C., van Ginneken, A.C., Bezzina, C.R., Alders, M., Escande, D., Mannens, M.M., Baro, I. Wilde, A.A. 2004. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109, 2394 2397.
4. Berthet, M., Denjoy, I., Donger, C., Demay, L., Hammoude, H., Klug, D., Schulze-Bahr, E., Richard, P., Funke, H., Schwartz, K., Coumel, P., Hainque, B. Guicheney, P. 1999. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation 99, 1464 1470.
5. Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M., Menendez, T.M., Brugada, J., Pollevick, G.D., Wolpert, C., Burashnikov E., Matsuo, K., Wu, Y.S., Guerchicoff, A., Bianchi, F., Giustetto, C., Schimpf, R., Brugada, P. Antzelevitch, C. 2004. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109, 30 35.
6. Casimiro, M.C., Knollmann, B.C., Ebert, S.N., Vary, J.C., Jr., Greene, A.E., Franz, M.R., Grinberg, A., Huang, S.P. Pfeifer, K. 2001. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci USA 98, 2526 2531.
7. Casis, O., Olesen, S.P. Sanguinetti, M.C. 2006. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol 69, 658 665.
8. Charpentier, F., Merot, J., Riochet, D., Le Marec, H. Escande, D. 1998. Adult KCNE1-knockout mice exhibit a mild cardiac cellular phenotype. Biochem Biophys Res Commun 251, 806 810.
9. Chinushi, M., Aizawa, Y., Furushima, H., Inuzuka, H., Ojima, K. Shibata, A. 1995. Nicorandil suppresses a hump on the monophasic action potential and torsade de pointes in a patient with idiopathic long QT syndrome. Jpn Heart J 36, 477 481.
10. Clancy, C.E., Kurokawa, J., Tateyama, M., Wehrens, X.H. Kass, R.S. 2003. K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation. Annu Rev Pharmacol Toxicol 43, 441 461.
11. Cordeiro, J.M., Brugada, R., Wu, Y.S., Hong, K. Dumaine, R. 2005. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome. Cardiovasc Res 67, 498 509.
12. Fabritz, L., Kirchhof, P., Franz, M.R., Eckardt, L., Monnig, G., Milberg, P., Breithardt, G. Haverkamp, W. 2003. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 98, 25 32.
13. Gussak, I. Antzelevitch, C. 2000. Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. J Electrocardiol 33, 299 309.
14. Hansen, R.S., Diness, T.G., Christ, T., Demnitz, J., Ravens, U., Olesen, S.P. Grunnet, M. 2006. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 69, 266 277.
15. Ito, H., Taniyama, Y., Iwakura, K., Nishikawa, N., Masuyama, T., Kuzuya, T., Hori, M., Higashino, Y., Fujii, K. Minamino, T. 1999. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33, 654 660.
16. 2+ current. Circ Res 64, 977 990.
17. Keating, M.T. Sanguinetti, M.C. 2001. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104, 569 580.
18. Killeen, M.J., Thomas, G., Gurung, I.S., Goddard, C.A., Fraser, J.A., Mahout-Smith, M.P., Colledge, W.H., Grace, A.A. Huang, C.L. 2007a. Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart. Acta Physiol, 189, 33 46.
19. Killeen, M.J., Gurung, I.S., Thomas, G., Stokoe, K.S., Grace, A.A. Huang, C.L. 2007b. Separation of early after depolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis. Acta Physiol, 191, 43 58.
20. Kirchhof, P., Fabritz, L., Kilic, A., Begrow, F., Breithardt, G. Kuhn, M. 2004. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice. J Mol Cell Cardiol 36, 691 700.
21. Kuo, H.C., Cheng, C.F., Clark, R.B., Lin, J.J., Lin, J.L., Hoshijima, M., Nguyen-Tran, V.T., Gu, Y., Ikeda, Y., Chu, P.H., Ross, J., Giles, W.R. Chien, K.R. 2001. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107, 801 813.
22. Liu, G.X., Zhou, J., Nattel, S. Koren, G. 2004. Single-channel recordings of a rapid delayed rectifier current in adult mouse ventricular myocytes: basic properties and effects of divalent cations. J Physiol 556, 401 413.
23. Markham, A., Plosker, G.L. Goa, K.L. 2000. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs 60, 955 974.
24. Milberg, P., Eckardt, L., Bruns, H.J., Biertz, J., Ramtin, S., Reinsch, N., Fleischer, D., Kirchhof, P., Fabritz, L., Breithardt, G. Haverkamp, W. 2002. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. J Pharmacol Exp Ther 303, 218 225.
25. Miyazaki, T., Moritani, K., Miyoshi, S., Asanagi, M., Zhao, L.S., Mitamura, H., Mitamura, H. Ogawa, S. 1995. Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia. J Cardiovasc Pharmacol 26, 949 956.
26. Morrissey, A., Rosner, E., Lanning, J., Parachuru, L., Dhar Chowdhury, P., Han, S., Lopez, G., Tong, X., Yoshida, H., Nakamura, T.Y., Artman, M., Giblin J.P., Tinker A. Coetzee W.A. 2005. Immunolocalization of KATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol 5, 1.
27. Nerbonne, J.M., Nichols, C.G., Schwarz, T.L. Escande, D. 2001. Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here? Circ Res 89, 944 956.
28. NICE. 2000. Guidance on the use of implantable cardioverter defibrillators for arrhythmias, pp. 1 15. Department of Health, London, UK.
29. Nuss, H.B., Marban, E. Johns, D.C. 1999. Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes. J Clin Invest 103, 889 896.
30. Papadatos, G.A., Wallerstein, P.M., Head, C.E., Ratcliff, R., Brady, P.A., Benndorf, K., Saumarez, R.C., Trezise, A.E., Huang, C.L., Vandenberg, J.I., Colledge, W.H. Grace, A.A. 2002. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci USA 99, 6210 6215.
31. Priori, S.G., Pandit, S.V., Rivolta, I., Berenfeld, O., Ronchetti, E., Dhamoon, A., Napolitano, C., Anumonwo, J., di Barletta, M.R., Gudapakkam, S., Bosi, G., Stramba-Badiale, M. Jalife, J. 2005. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96, 800 807.
32. Roden, D.M. 2004. Drug-induced prolongation of the QT interval. N Engl J Med 350, 1013 1022.
33. Roden, D.M. Hoffman, B.F. 1985. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. Circ Res 56, 857 867.
34. Saumarez, R.C. Grace, A.A. 2000. Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc Res 47, 11 22.
35. Shimizu, W. Antzelevitch, C. 2000. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation 102, 706 712.
36. Shimizu, W., Kurita, T., Matsuo, K., Suyama, K., Aihara, N., Kamakura, S., Towbin, J.A. Shimomura, K. 1998. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Circulation 97, 1581 1588.
37. + channels by pinacidil and nicorandil. Br J Pharmacol 124, 985 991.
38. Shivkumar, K. Valderrabano, M. 2004. Use of potassium channel openers for pharmacologic modulation of cardiac excitability. J Cardiovasc Electrophysiol 15, 821 823.
39. Spinelli, W., Follmer, C., Parsons, R. Colatsky, T. 1990. Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs. Eur J Pharmacol 179, 243 252.
40. Splawski, I., Shen, J., Timothy, K.W., Lehmann, M.H., Priori, S., Robinson, J.L., Moss, A.J., Schwartz, P.J., Towbin, J.A., Vincent, G.M. Keating, M.T. 2000. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102, 1178 1185.
41. Stokoe, K.S., Balasubramaniam, R., Goddard, C.A., Colledge, W.H., Grace, A.A. Huang, C.L. 2007a. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts. J Physiol 581, 255 275.
42. Stokoe, K.S., Thomas, G., Goddard, C.A., Colledge, W.H., Grace, A.A. Huang, C.L. 2007b. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/{Delta} murine hearts modelling long QT syndrome 3. J Physiol 578, 69 84.
43. 2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3. J Physiol 578, 85 97.
44. Thomas, G., Killeen, M.J., Gurung, I.S., Hakim, P., Balasubramaniam, R., Goddard, C.A., Grace, A.A. Huang, C.L. 2007b. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. J Physiol 578, 99 114.
45. Wang, Y., Cheng, J., Joyner, R.W., Wagner, M.B. Hill, J.A. 2006. Remodeling of early-phase repolarization: a mechanism of abnormal impulse conduction in heart failure. Circulation 113, 1849 1856.
46. Yang, T. Roden, D.M. 1996. Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. Circulation 93, 407 411.
47. Yang, J.N., Tiselius, C., Dare, E., Johansson, B., Valen, G. Fredholm, B.B. 2007. Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol, 190, 63 75.